News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EKR Therapeutics, Inc. Announces Senior Management Change


10/14/2011 9:28:36 AM

BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc. a privately held specialty pharmaceutical company, announced today that Rolf A. Classon, chairman of the board and independent director, will not stand for reelection and has resigned effective immediately.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES